This inventor holds 1 USPTO granted patent. Top assignee: Beecham Group Plc. Active years: 1986.
Company Filing History:
Years Active: 1986
Title: King Luk - Innovator in β-Lactamase Inhibitors
Introduction
King Luk is a notable inventor based in Cranleigh, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that enhance the effectiveness of antibiotics.
Latest Patents
King Luk holds a patent for "6-Substituted derivatives of clavulanic acid." This invention provides compounds that are β-lactamase inhibitors, which are crucial in improving the efficacy of penicillins and cephalosporins. The patent describes compounds of the formula (II) and their salts and esters, where R₁ can be a hydrogen atom or an alkyl group of 1-4 carbon atoms, and R₂ can also be a hydrogen atom or an alkyl group of 1-4 carbon atoms, or can be joined to R₁ to form part of a 5-, 6-, or 7-membered carbocyclic ring.
Career Highlights
Throughout his career, King Luk has been associated with Beecham Group Plc, where he has contributed to various innovative projects. His work has focused on enhancing antibiotic effectiveness, which is vital in combating bacterial resistance.
Collaborations
King Luk has collaborated with Thomas T Howarth, working together on projects that aim to advance pharmaceutical research and development.
Conclusion
King Luk's contributions to the field of pharmaceuticals, particularly through his patent on β-lactamase inhibitors, highlight his role as an innovator in enhancing antibiotic effectiveness. His work continues to impact the medical community positively.